Fulcrum Therapeutics Inc (FULC)
2.97
-0.02
(-0.67%)
USD |
NASDAQ |
Nov 21, 16:00
2.97
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 80.00M |
March 31, 2024 | |
December 31, 2023 | 0.871M |
September 30, 2023 | 0.759M |
June 30, 2023 | 0.88M |
March 31, 2023 | 0.295M |
December 31, 2022 | 0.685M |
September 30, 2022 | 1.183M |
June 30, 2022 | 1.882M |
Date | Value |
---|---|
March 31, 2022 | 2.592M |
December 31, 2021 | 5.058M |
September 30, 2021 | 4.935M |
June 30, 2021 | 4.381M |
March 31, 2021 | 4.789M |
December 31, 2020 | 4.225M |
September 30, 2020 | 1.848M |
June 30, 2020 | 2.00M |
March 31, 2020 | 0.75M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.295M
Minimum
Mar 2023
80.00M
Maximum
Jun 2024
6.890M
Average
1.882M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
Bioventus Inc | 138.96M |
Arcturus Therapeutics Holdings Inc | 38.82M |
Johnson & Johnson | 22.47B |
Pfizer Inc | 17.70B |
Tenon Medical Inc | 0.887M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -21.70M |
Total Expenses (Quarterly) | 23.06M |
EPS Diluted (Quarterly) | -0.35 |
Enterprise Value | -97.04M |
Earnings Yield | -10.44% |
Normalized Earnings Yield | -11.78 |